Literature DB >> 850076

Interferon production in lymphocyte cultures after rubella infection in humans.

E Buimovici-Klein, K E Weiss, L Z Cooper.   

Abstract

When stimulated with rubella virus irradiated with ultraviolet light, cultures of lymphocytes from individuals immune to rubella responded with production of 12-14 times more interferon than did cultures of lymphocytes from individuals susceptible to rubella. This property may be retained throughout life, since it was seen in individuals who had had rubella in their recent and remote pasts. Peak levels of interferon were detected six days after stimulation of lymphocytes with rubella virus antigen. In contrast, phytohemagglutinin induced production of interferon equally well in cultures of lymphocytes from persons immune and persons susceptible to rubella, with levels peaking three days after stimulation. Since there was a positive correlation among titers of hemagglutination-inhibiting antibody to rubella virus, incorporation of [14C]thymidine, and production of interferon after stimulation of lymphocyte cultures by rubella virus, interferon synthesis may be considered to be another measurable parameter of cell-mediated immunity in rubella.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850076     DOI: 10.1093/infdis/135.3.380

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Rheumatoid arthritis--a virus disease?

Authors:  A M Denman
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 2.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

3.  Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection.

Authors:  R C Gehrz; T E Leonard
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

4.  Low level rubella immunity detected by ELISA and specific lymphocyte transformation.

Authors:  E Buimovici-Klein; A J O'Beirne; S J Millian; L Z Cooper
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

5.  Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis.

Authors:  A Møller-Larsen; S Haahr; F T Black
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapy.

Authors:  J S Wolinsky; P C Dau; E Buimovici-Klein; J Mednick; B O Berg; P B Lang; L Z Cooper
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

7.  Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella.

Authors:  P Lebon; F Daffos; A Checoury; L Grangeot-Keros; F Forestier; J E Toublanc
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

8.  Immunosuppression and isolation of rubella virus from human lymphocytes after vaccination with two rubella vaccines.

Authors:  E Buimovici-Klein; L Z Cooper
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

Authors:  M McCarthy; A Lovett; R H Kerman; A Overstreet; J S Wolinsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.